Koronis Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 45.38%
- Profit Growth 32.51%
- Ebitda 106.73%
- Net Worth 12.30%
- Total Assets 20.56%
About Koronis Pharmaceutical
Koronis Pharmaceutical Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 November 2011 and has a history of 13 years and three months. Its registered office is in Cachar, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Gobinda Chakravarty, Geetopriyo Chokroborty, and Aparna Chakraborty serve as directors at the Company.
Company Details
- Location
Cachar, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909AS2011PTC010763
- Company No.
010763
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Koronis Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geetopriyo Chokroborty  | Managing Director | 08-Nov-2011 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gobinda Chakravarty | Director | 17-Jul-2014 | Current |
| Aparna Chakraborty | Director | 17-Jul-2014 | Current |
Financial Performance of Koronis Pharmaceutical.
Koronis Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 45.38% increase. The company also saw a substantial improvement in profitability, with a 32.51% increase in profit. The company's net worth Soared by an impressive increase of 12.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Koronis Pharmaceutical?
Unlock access to Koronis Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Silchar Heart Care And Research Centre Pvt. Ltd.Gobinda Chakravarty is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Koronis Pharmaceutical?
Unlock and access historical data on people associated with Koronis Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koronis Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koronis Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
